NNVC — NanoViricides Cashflow Statement
0.000.00%
Last trade - 00:00- $26.15m
- $24.59m
Annual cashflow statement for NanoViricides, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.82 | -8.11 | -8.59 | -8.29 | -9.47 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.444 | 1.28 | 0.372 | 0.223 | 0.224 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.54 | 0.215 | 1.8 | 0.997 | 0.02 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.21 | -5.89 | -5.67 | -6.32 | -8.48 |
| Capital Expenditures | -0.239 | -0.324 | -0.152 | -0.157 | -0.057 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.239 | -0.324 | -0.152 | -0.157 | -0.057 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.3 | -0.235 | -0.095 | 3.12 | 5.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.81 | -6.45 | -5.92 | -3.35 | -3.24 |